Karmazyn M, Cook M A
Department of Pharmacology and Toxicology, University of Western Ontario, London, Canada.
Circ Res. 1992 Nov;71(5):1101-10. doi: 10.1161/01.res.71.5.1101.
Adenosine has been shown to protect the ischemic and reperfused myocardium. To examine whether the protective effect of the nucleoside is mediated by modulation of oxidative stress, isolated rat hearts were perfused for 30 minutes with 100 microM H2O2 or an exogenous free radical-generating system consisting of purine (3.06 mM) and xanthine oxidase (10 units/l) in the presence or absence of drugs acting on adenosine A1 or A2 receptors. H2O2 alone produced a greater than 90% loss in contractility concomitant with a threefold elevation in resting tension, although these effects occurred in the absence of ultrastructural damage. Two A1 receptor agonists N6-cyclopentyladenosine (CPA, 1 microM) and R(-)-N6-(2-phenylisopropyl)adenosine (R-PIA, 1 microM) significantly attenuated the cardiodepressant effects of H2O2 and depressed the elevation in resting tension; however, only the effect of CPA was found to be significant with regard to the latter parameter. A similar concentration of S(+)-N6-(2-phenylisopropyl)adenosine (S-PIA), a markedly less potent A1 receptor agonist, was found to be without beneficial effect. However, a significant protective effect against both the reduction in contractility and the elevation in resting tension was seen with a 10-fold elevation in the concentration of S-PIA (10 microM). The protective effects on functional parameters were associated with preservation of high-energy phosphate and adenine nucleotide contents after 30 minutes of H2O2 treatment. The salutary effects of all drugs were reversed in the presence of the A1 receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (0.5 microM). An A2 receptor agonist 2-[p-(carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine, termed CGS 21680 (1 microM), failed to alter the cardiac response to H2O2 with regard to all parameters studied. Neither a 50% reduction in external CaCl2 concentration nor treatment with 10 microM DL-propranolol exerted salutary effects against H2O2-induced dysfunction. None of the A1 receptor agonists modulated the response to purine plus xanthine oxidase. Our results demonstrate a selective protective effect of adenosine A1 receptor activation against the cardiac toxicity of H2O2 and provide, at least in part, a basis for the cardioprotective actions of adenosine and its analogues.
腺苷已被证明可保护缺血再灌注心肌。为了研究这种核苷的保护作用是否通过调节氧化应激介导,在有或没有作用于腺苷A1或A2受体的药物存在的情况下,将离体大鼠心脏用100 microM过氧化氢或由嘌呤(3.06 mM)和黄嘌呤氧化酶(10单位/升)组成的外源性自由基生成系统灌注30分钟。单独使用过氧化氢会导致收缩力损失超过90%,同时静息张力升高三倍,尽管这些效应在没有超微结构损伤的情况下发生。两种A1受体激动剂N6-环戊基腺苷(CPA,1 microM)和R(-)-N6-(2-苯异丙基)腺苷(R-PIA,1 microM)显著减轻了过氧化氢的心脏抑制作用,并降低了静息张力的升高;然而,就后一参数而言,仅发现CPA的作用具有显著性。浓度相似的S(+)-N6-(2-苯异丙基)腺苷(S-PIA),一种效力明显较低的A1受体激动剂,未发现有有益作用。然而,当S-PIA浓度升高10倍(10 microM)时,对收缩力降低和静息张力升高均有显著的保护作用。对功能参数的保护作用与过氧化氢处理30分钟后高能磷酸盐和腺嘌呤核苷酸含量的保存有关。在A1受体拮抗剂1,3-二丙基-8-环戊基黄嘌呤(0.5 microM)存在的情况下,所有药物的有益作用均被逆转。一种A2受体激动剂2-[对-(羧乙基)苯乙氨基]-5'-N-乙基羧酰胺腺苷,称为CGS 21680(1 microM),在所研究的所有参数方面均未改变心脏对过氧化氢的反应。外部氯化钙浓度降低50%或用10 microM DL-普萘洛尔处理均未对过氧化氢诱导的功能障碍产生有益作用。没有一种A1受体激动剂调节对嘌呤加黄嘌呤氧化酶的反应。我们的结果证明了腺苷A1受体激活对过氧化氢心脏毒性的选择性保护作用,并至少部分地为腺苷及其类似物的心脏保护作用提供了基础。